Literature DB >> 8523048

Docetaxel: current status and future prospects.

E Eisenhauer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8523048     DOI: 10.1200/JCO.1995.13.12.2865

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  9 in total

1.  Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293.

Authors:  A I Einzig; D Neuberg; S C Remick; D D Karp; P J O'Dwyer; J A Stewart; A B Benson
Journal:  Med Oncol       Date:  1996-06       Impact factor: 3.064

2.  The Role of Molecular Imaging in Drug Delivery.

Authors:  Gang Niu; Xiaoyuan Chen
Journal:  Drug Deliv (Lond)       Date:  2009

Review 3.  [Docetaxel (taxotere) in non-small-cell bronchial carcinoma].

Authors:  C Manegold
Journal:  Med Klin (Munich)       Date:  1997-09-15

4.  Evaluation of biodistribution and anti-tumor effect of a dimeric RGD peptide-paclitaxel conjugate in mice with breast cancer.

Authors:  Qizhen Cao; Zi-Bo Li; Kai Chen; Zhanhong Wu; Lina He; Nouri Neamati; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03-29       Impact factor: 9.236

5.  Feasibility study of gemcitabine plus docetaxel in advanced or recurrent uterine leiomyosarcoma and undifferentiated endometrial sarcoma in Japan.

Authors:  Tadao Takano; Hitoshi Niikura; Kiyoshi Ito; Satoru Nagase; Hiroki Utsunomiya; Takeo Otsuki; Masafumi Toyoshima; Hideki Tokunaga; Michiko Kaiho-Sakuma; Naomi Shiga; Tomoyuki Nagai; Sota Tanaka; Ai Otsuki; Hiroki Kurosawa; Shogo Shigeta; Keita Tsuji; Takuhiro Yamaguchi; Nobuo Yaegashi
Journal:  Int J Clin Oncol       Date:  2013-10-24       Impact factor: 3.402

6.  Phase II study of docetaxel in patients with metastatic pancreatic cancer: a Japanese cooperative study. Cooperative Group of Docetaxel for Pancreatic Cancer in Japan.

Authors:  S Okada; Y Sakata; S Matsuno; M Kurihara; Y Sasaki; Y Ohashi; T Taguchi
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

Review 7.  Sex Differences in Taxane Toxicities.

Authors:  Nicole N Chmielewski; Charles L Limoli
Journal:  Cancers (Basel)       Date:  2022-07-08       Impact factor: 6.575

8.  A Phase II Study of Docetaxel in Chemotherapy-Naïve Patients With Recurrent or Metastatic Adult Soft Tissue Sarcoma.

Authors:  V Bramwell; M Blackstein; K Belanger; S Verma; S Beare; E Eisenhauer
Journal:  Sarcoma       Date:  1998

9.  Feasibility and efficacy of gemcitabine and docetaxel combination chemotherapy for bone and soft tissue sarcomas: multi-institutional retrospective analysis of 134 patients.

Authors:  Kazuhiro Tanaka; Susumu Joyama; Hirokazu Chuman; Hiroaki Hiraga; Hideo Morioka; Hideki Yoshikawa; Masami Hosaka; Mitsuru Takahashi; Tadahiko Kubo; Hiroshi Hatano; Mitsunori Kaya; Junya Toguchida; Yoshihiro Nishida; Akihito Nagano; Hiroshi Tsumura; Yukihide Iwamoto
Journal:  World J Surg Oncol       Date:  2016-12-08       Impact factor: 2.754

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.